Morning Briefing
Summaries of health policy coverage from major news organizations
Eli Lilly CEO Says U.S. Drugmakers' Biggest Challenge Is Sustaining Innovation
Drugmakers are facing an array of challenges, such as lawsuits and patent losses, but also new opportunities including global growth and an expected surge in the number of U.S. residents with health insurance.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
